Antimicrobial Working Group
AWG is a 501(c)(6) in support of public policy regarding antimicrobial drugs/diagnostics
Based in DC
AI Overview
With $110K in lobbying spend across 6 quarterly filings, Antimicrobial Working Group is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2022.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $40K |
| 2022 | $70K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Antimicrobial Working Group disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations
Federal funding for anitmicrobial resistance research and development; FY 22 Appropriations bills;
Federal funding for antimicrobial resistence research and development: FY 22 Appropriations bills;
Federal funding for antimicrobial resistance research and development: Final Omnibus Appropriations bill for FY 22; FY 23 federal budget and FY 23 appropriations.
Federal funding for antimicrobial resistance research and development: FY 23 federal budget and FY 23 appropriations.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.